This article is available to subscribers. Subscribe now. Already have an account? Sign in

Medical IntelligenceFree PreviewArchive

A Cellular Defect in Hereditary Vitamin-D-Dependent Rickets Type II: Defective Nuclear Uptake of 1,25-Dihydroxyvitamin D in Cultured Skin Fibroblasts

List of authors.
  • Charles Eil, M.D., Ph.D.,
  • Uri A. Liberman, M.D., Ph.D.,
  • John F. Rosen, M.D.,
  • and Stephen J. Marx, M.D.

VITAMIN-D-dependent (or pseudo-vitamin-D-deficient) rickets is characterized by clinical and biochemical features of vitamin-D-deficient rickets and by remission of these features during treatment with supraphysiologic doses of vitamin D or of 25-hydroxyvitamin D (25-(OH)D).1 , 2 It is often hereditary, with patterns suggestive of autosomal-recessive transmission. In members of several kindreds who are classified as having vitamin-D-dependent rickets Type I, concentrations of 1,25-dihydroxyvitamin D (1,25(OH)2D) in serum have been low3 , 4; these patients can be treated with doses of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3) that are estimated to maintain a normal average serum concentration and turnover of this metabolite.3 Presumably, . . .

Funding and Disclosures

Supported in part by grants (ES-01060–06 and RR-53) from the National Institutes of Health.

We are indebted to the National Institute of Child Health and Human Development, particularly Dr. Lynn Loriaux, for generous support.

Author Affiliations

From the Endocrinology Branch, Department of Medicine, National Naval Medical Center and Uniformed Services University of the Health Sciences, Bethesda, Md.; the Metabolic Diseases Branch, National Institute of Arthritis, Metabolism, and Digestive Diseases, Bethesda, Md.; and the Department of Pediatrics, Albert Einstein College of Medicine, Montefiore Hospital and Medical Center, Bronx, N.Y. Address reprint requests to Dr. Marx at Bldg. 10, Rm. 9D–20, National Institutes of Health, Bethesda, MD 20205.

Print Subscriber? Activate your online access.